Quantitative Systematic Strategies LLC Immunovant, Inc. Transaction History

Quantitative Systematic Strategies LLC

  • $0
  • Q3 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 06, 2021
SELL
$13.08 - $49.6 $90,448 - $342,984
-6,915 Closed
0 $0
Q4 2020

Feb 09, 2021
SELL
$36.36 - $52.71 $210,706 - $305,454
-5,795 Reduced 45.59%
6,915 $319,000
Q3 2020

Nov 09, 2020
SELL
$22.61 - $38.9 $98,579 - $169,604
-4,360 Reduced 25.54%
12,710 $447,000
Q2 2020

Aug 04, 2020
BUY
$13.87 - $28.44 $21,651 - $44,394
1,561 Added 10.07%
17,070 $416,000
Q1 2020

May 06, 2020
BUY
$8.36 - $17.13 $129,655 - $265,669
15,509 New
15,509 $241,000

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email